Gestational diabetes mellitus in a cohort of HIV-1 infected women

被引:34
作者
Gonzalez-Tome, M. I. [1 ]
Amador, J. T. Ramos [2 ]
Guillen, S. [2 ]
Solis, I. [3 ]
Fernandez-Ibieta, M. [2 ]
Munoz, E. [4 ]
Almeda, J. [5 ]
Rojano, X. [5 ]
Rojo, P. [1 ]
Nieto, O.
机构
[1] Hosp 12 Octubre, Dept Immunodeficiencies, E-28041 Madrid, Spain
[2] Hosp Getafe, Dept Pediat, Madrid, Spain
[3] Hosp Getafe, Dept Gynecol, Madrid, Spain
[4] Hosp 12 Octubre, Dept Gynecol, E-28041 Madrid, Spain
[5] CEESCAT Ctr Epidemiol Studies HIV AIDS Catalonia, Barcelona, Spain
关键词
antiretroviral therapy; gestational diabetes mellitus; HIV infection; pregnancy; protease inhibitor;
D O I
10.1111/j.1468-1293.2008.00639.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives We undertook a prospective study to estimate the prevalence of gestational diabetes mellitus (GDM) and associated risk factors in a cohort of 669 HIV-1 infected women. Methods The O'Sullivan and glucose tolerance tests were performed during regular visits of 609 mothers. Results The median age of the cohort was 30.7 years (range 16-44), with most women having had heterosexual contact (67%). The majority were in Centers for Disease Control (CDC) category A (71%) and 53% exhibited hepatitis C co-infection. Median viral load and CD4 count at third trimester were 545 cells/mu L (range 139-1690 cells/mu L) and 1.9 log (range 1.7-5.4), respectively. Seventy-four per cent of the patients were treated with highly active antiretroviral therapy (HAART), of whom 41% received a protease inhibitor (PI). An above-average prevalence of 7% [95% confidence interval (CI) 5.2-9.5] for positive GDM diagnosis was found. Risk factors associated with GDM in univariate analysis included older age, hepatitis C co-infection, stavudine and PI exposure. However, only older age [adjusted odds ratio (AOR) 1.09, 95% CI 1-1.1] and PI exposure (AOR 2.4, 95% CI 1-5.3) remained as independent risk factors for GDM development in multivariate analysis. Conclusions In our cohort, the prevalence of GDM appears to be increased, with older age and PI exposure contributing as significant independent risk factors.
引用
收藏
页码:868 / 874
页数:7
相关论文
共 35 条
[11]   Disorders of glucose metabolism in patients infected with human immunodeficiency virus [J].
Dubé, MP .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1467-1475
[12]   Effect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant women [J].
El Beitune, P ;
Duarte, G ;
Foss, MC ;
Montenegro, RM ;
Spara, P ;
Quintana, SM ;
Figueiró-Filho, EA ;
da Costa, AG ;
Mauad, F .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (01) :59-63
[13]  
HARRIS M, 1979, DIABETES, V28, P1039
[14]   Effects of HIV protease inhibitor therapy on lipid metabolism [J].
Hui, DY .
PROGRESS IN LIPID RESEARCH, 2003, 42 (02) :81-92
[15]   Prevalence of gestational diabetes mellitus:: variations related to screening strategy used [J].
Jiménez-Moleón, JJ ;
Bueno-Cavanillas, A ;
Luna-del-Castillo, JD ;
García-Martín, M ;
Lardelli-Claret, P ;
Gálvez-Vargas, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (06) :831-837
[16]   Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women [J].
Justman, JE ;
Benning, L ;
Danoff, A ;
Minkoff, H ;
Levine, A ;
Greenblatt, RM ;
Weber, K ;
Piessens, E ;
Robison, E ;
Anastos, K .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (03) :298-302
[17]   The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection [J].
Lo, JC ;
Kazemi, MR ;
Hsue, PY ;
Martin, JN ;
Deeks, SG ;
Schambelan, M ;
Mulligan, K .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1335-1340
[18]   Incidence of gestational diabetes mellitus according to different diagnostic criteria in the southeast Madrid area.: Influence of diagnosis on materno-fetal parameters [J].
Martínez, JJG ;
Ruiz, FA ;
Hernández, EL ;
Candil, SD .
REVISTA CLINICA ESPANOLA, 2002, 202 (03) :136-141
[19]   The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons [J].
Mehta, SH ;
Moore, RD ;
Thomas, DL ;
Chaisson, RE ;
Sulkowski, MS .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (05) :577-584
[20]   Metabolic complications associated with the fuse of highly active antiretroviral therapy in HIV-1-infected adults [J].
Monier, PL ;
Wilcox, R .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (01) :48-56